| Revenue growth | Q2 +31.4%; H1 +28.7% YoY |
|---|---|
| Margins | Q2 IndAS EBITDA margin 27.9% vs 28.4%; PAT margin 8.5% (+134bps) |
| Demand visibility | H1 patients served +28.5%; surgeries +18.8% |
Growth
Q2 revenue +31.4% to ₹655 Cr; Q2 PAT +55.8% to ₹57 Cr. H1 revenue +28.7%; H1 PAT +50.1% to ₹112 Cr.
Outlook
FY27E: 65 facility additions (55 surgical), with 26 planned in H2. Zambia and Ethiopia expansion planned. No explicit revenue or profit guidance.
Risks
Four primary facilities closed in H1 (Janipur, Zirakpur, Peer Muchalla). Net debt ₹29 Cr in latest period versus earlier net cash. No explicit risk commentary.
Last quarter's promises, checked
Delivered
- Guided Q1+Q2 30 facilities (18+12) → H1 delivered 37 (= BEAT)
- Guided FY27 60 facilities (40 surgical) → now 65E (55 surgical), raised (= BEAT)
Missed
- Guided 30 H2 facility adds → now 26 planned for H2 (= MISS)
Investor Presentation filed with BSE, NSE: AGARWALEYE. Summary written with AI assistance from the document.
Dr. Agarwals Health Care Ltd: key numbers
- Share price
- ₹511.70
- Market cap
- ₹16,222 Cr
- Revenue (annual)
- ₹2,080 Cr
- Net profit (annual)
- ₹133.2 Cr
- P/E (TTM)
- 109.3×Sector 54.5×
- Promoter holding
- 32.33%-0.01% QoQ
- FII holding
- 49.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwals Health Care Ltd
All →Dr. Agarwals Health Care Earnings Call Transcript: Key Takeaways
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%), network-led growth; India EBITDA margin flat near 28%.
Dr. Agarwals Health Care Management Change
Dr Agarwals Health Care reports Mr. Amar Agarwal's redesignation from Chairman and Non-Executive Director to Executive Director, effective 1 November 2026. The change was approved at a board meeting held on 5 November 2026.
Dr. Agarwals Health Care Financial Results
Dr. Agarwal's H1 FY27 revenue rose 28.7% to Rs 1,269 crore; PAT rose 50.1% to Rs 112 crore. Amar Agarwal's executive chairman appointment awaits postal ballot approval.
Dr. Agarwals Health Care Board Meeting Date
Dr. Agarwal's Health Care schedules a board meeting on November 5, 2026 to consider Q2 results. An earnings call follows at 6:30 PM IST that day.
Dr. Agarwals Health Care Merger & Restructuring Worth ₹711.2 Cr
Dr. Agarwals Health Care Limited has completed the merger of Dr. Agarwal's Eye Hospital Limited into itself for a total transaction value of ₹711.21 Crore.
- Value
- ₹711.2 Cr
Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care Limited allotted 18,200 equity shares upon the exercise of vested ESOPs. The transaction is valued at approximately ₹0.24 Crore.
- Value
- ₹0.24 Cr